News & Reports

Have some news you want to share with the Oregon Bio community?  Fill out our submission form.

Portland Mayoral Candidates Speak Out About Bioscience Industry’s Growth and Support

Tuesday, September 19, 2012

(Portland, Ore.) – The job description for Portland, Oregon’s next mayor is clearly economic development, at least that’s where the current two mayoral candidates, Charlie Hales and Jefferson Smith, agree. The candidates also agree in prioritizing access to capital and incentives to grow investments in the sector. However, they differ in how to make that happen.

“Both candidates acknowledge that they want to keep the life science and biotech industry growing here in Portland,” says Oregon Bioscience Association’s […]

September 19, 2012 |

Medcure Anatomical Tissue Bank Provides New Service In Europe

PORTLAND, Oregon –August 20, 2012 – MedCure announced it is opening a non-transplant anatomical tissue bank on September 1st, 2012 in Amsterdam, Netherlands. This anatomical tissue bank in Amsterdam is the first of its kind and will provide much needed human cadaveric tissue specimens to be utilized by universities and medical researchers and educators in Europe.

“It has been traditionally difficult for researchers and physicians to acquire unembalmed cadavers for their research, education, or surgical training in Europe,” says April Salsbury, […]

August 28, 2012 |

Content and Keynote Speakers Announced for Annual Conference

Oregon Bio 2012: Bioscience Digitization and Discovery is the theme for this first-ever, two day Oct. 9 and 10 event

FOR IMMEDIATE RELEASE – August 22, 2012
CONTACT: Dennis McNannay, executive director, Oregon Bio, 503.548.4432
Dianne Danowski Smith, board member, Oregon Bio, 503.201.7019

(Portland, Ore.) — The “father” of Personalized Medicine, LeRoy Hood, M.D., as well as James Karis, CEO of CollabRx, Inc., and Brad Vale, vice president of venture investing for Johnson & Johnson and others will deliver keynote speeches at this year’s state-and region-wide bioscience industry […]

August 22, 2012 |

Mitch Greenlick Publishes New Book

Mitch Greenlick has produced a book that is as unusual as it is stimulating. The Cat-Herd’s Toolkit is both an e-mail epistolary novel and a discourse on managing professionals in complex organizations. Each chapter of the novel serves as case material for the discursive material that follows. Taken together, they provide the research manager with explicit instructions on how to develop and manage a research culture that will lead to organizational success.

Greenlick has spent decades as a successful health services […]

August 16, 2012 |

Portland Awarded Conference Aimed at Small Business Funding

National Conference held in Portland, Oregon to teach small businesses how to compete for $2.5 billion in federal grants.

PORTLAND, ORE – August 1, 2012 – Beating out hundreds for the privilege, non-profit organization, Micro-enterprise Inventors Program of Oregon (MIPO) will host the annual Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) National Conference from November 13 – 15, 2012 in Portland, Oregon. The three day conference will draw more than 600 entrepreneurs, businesses, government agencies, innovators, universities […]

August 9, 2012 |

MolecularMD Submits Premarketing Approval Application to the FDA

FOR IMMEDIATE RELEASE – July 30, 2012
Contact: Katherine Clock 503-459-4974

MOLECULARMD SUBMITS PREMARKETING APPROVAL APPLICATION TO THE FDA FOR ITS BCR-ABL T315I MUTATION TEST, A COMPANION DIAGNOSTIC TO PONATINIB, AN INVESTIGATIONAL BCR-ABL INHIBITOR

(Portland, Ore.- July 30, 2012) – MolecularMD Corp. today announced that it has submitted its application for Premarket Approval (PMA) of the MolecularMD BCR-ABL T315I Mutation Test to the U.S. Food and Drug Administration (FDA). This test detects the T315I mutation in BCR-ABL RNA transcripts in blood using Sanger […]

Bioscience Grants in Oregon

The Coalition for Life Sciences reports that Oregon also received 285 NSF-funded grants totaling over $80,527,000.00. This same organization reports what NIH funding means for Oregon’s economy:

Each NIH dollar invested in Oregon generates $2.21 in new state business activity
$600 million in increased output of goods and services to Oregon
4,955 new jobs, with an average annual salary of $44,011
$218 million in taxable wages in the state

Download the NIH award PDF

FEI buys Visualization Sciences Group in $55M deal

Cathy Cheney | Portland Business Journal
FEI CEO Don Kania said the purchase of VSG will expand his firm’s visualization capabilities.

FEI Co. announced Wednesday that it has expanded its imaging and visualization capabilities with the acquisition of Visualization Sciences Group for $55 million.

VSG of Bordeaux, France, makes 3D visualization software products and tools for customers in the oil and gas, geosciences, mining, life sciences, materials sciences and other industries. The company employs 88 and through the end of fiscal year in […]

Galena Biopharma Issued NeuVax(TM) U.S. Patent

Patent strengthens NeuVax Intellectual Property position for treating Phase 3 target population of low-to-intermediate (IHC 1+/2+) HER2 patients.

Provides NeuVax exclusivity for this indication until 2028, not including any patent term extensions.
LAKE OSWEGO, Ore., July 18, 2012 (GLOBE NEWSWIRE) — Galena Biopharma, Inc. (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments, today announced the issuance of a key patent, originally allowed in March 2012, from the U.S. Patent and Trademark Office (USPTO) covering the use of its product […]

July 18, 2012 |

FDA clears medical device developed by OHSU and AMES Technology, Inc. for muscle and joint rehabilitation

FDA clears medical device developed by OHSU and AMES Technology, Inc. for muscle and joint rehabilitation

PORTLAND, Ore. – The Food and Drug Administration today granted 510(k) clearance to a muscle and joint rehabilitation medical device developed by OHSU Scientist Dr. Paul Cordo, Ph.D., and AMES Technology, Inc.

AMES is an Oregon Health & Science University spinoff company established to transform Dr. Cordo’s OHSU research findings into a rehabilitation medical device for use in hospitals and clinics. Today’s FDA clearance allows AMES […]

Scientific advisers to the C.D.C. have been discussing the details of federal guidance on who qualifies for a Pfizer-BioNTech booster shot and why. A recommendation by the panel is expected… [...]

NIH vouches for new kidney disease diagnostic that doesn't rely on faulty race-based calculations apark Thu, 09/23/2021 - 14:44 [...]

The discussion, which continues on Thursday, could result in most Americans qualifying for an extra shot, or only a select few. [...]

The most common method of assessing the condition may make Black patients seem less ill than they really are, some experts say. A new report calls for scrapping the formula. [...]

A lawsuit brought on by the Montana Medical Association is challenging the state's ban on employer vaccine mandates. The association, along with other hospitals and patient groups, filed a lawsuit Wednesday… [...]